baber/WOPTO huggingface dataset:
Patent NZ-248263-A (NZ)
Title: Peptide derivatives having human leucocyte elastase (hle) inhibiting properties; pharmaceutical composition
Inventor: VINCENT MICHEL
IPC: A61P29/00
Filed: 1993-07-27
Abstract: Compound of formula (I): <IMAGE>  in which:     R1 represents a substituted or unsubstituted alkyl,   R2 represents a substituted or unsubstituted alkyl, A represents, with the nitrogen or carbon atoms to which it is attached, a nitrogen-containing mono- or polycyclic structure, B represents any one of the radicals a to j as defined in the specification.   Medicinal products.
Patent NZ-268889-A (NZ)
Title: Method of monitoring the ovulation cycle status of a female by measurement of analyte body fluid concentration
Inventor: CATT MICHAEL
IPC: G01N33/53
Filed: 1994-06-24
Abstract: A method of monitoring the status of a current ovulation cycle of an individual female mammalian (generally human) subject, involving repeated testing of the body fluid concentration of at least one analyte, preferably estrone-3-glucuronide (E3G) of significance in relation to the status of the ovulation cycle, during at least the pre-ovulation phase of the current ovulation cycle of the individual subject, wherein testing for said analyte concentration during the current ovulation cycle conducted at least once during the interval spanning days 1 to 7 inclusive following the onset of menses, to establish a reference concentration value for analyte in the current cycle, and then testing is conducted repeatedly during a plurality of days, preferably commencing at least 5 numerical days in advance of the mean numerical day on which actual ovulation has occurred over one or more previous ovulation cycles in the same individual subject, analyte concentration values obtained during said repeated testing being compared with the reference concentration value to determine whether a concentration change indicative of imminent ovulation is occurring or has occurred since the previous test. The method can be based solely on E3G measurements.
Patent NZ-276888-A (NZ)
Title: Bleaching composition of hypochlorites and silicates of alkali metals and use in bleaching textiles
Inventor: AGOSTINI FRANCESCO
IPC: C11D3/02
Filed: 1994-11-04
Abstract: The use of an alkali metal salt of silicate in a liquid aqueous bleaching composition comprising an alkali metal hypochlorite, a strong source of alkalinity and optionally an alkali metal salt of carbonate is disclosed, for reducing the damage caused by hypochlorite on fabrics treated with the composition.
Patent NZ-278151-A (NZ)
Title: Aerobic fermentation apparatus with screw conveyor supplying bucket elevator and apparatus being driven and steered within fermentation tank
Inventor: KIM BAIK KI
IPC: C05F17/02
Filed: 1995-01-14
Abstract: PCT No. PCT/KR95/00005 Sec. 371 Date Oct. 3, 1996 Sec. 102(e) Date Oct. 3, 1996 PCT Filed Jan. 14, 1995 PCT Pub. No. WO95/21141 PCT Pub. Date Aug. 10, 1995An aerobic fermentation promoting device, a fermentation system and organic compost prepared by the system. The device promotes aerobic fermentation of compost materials by periodically mixing the compost materials together and by letting the compost materials come into contact with the outside air. The device is installed in a fermentation tank and has a rotatable screw conveyor unit, at least one bucket elevator, a drive unit and a steering unit. The compost is produced by charging moisture control materials in the tank, uniformly spraying excrement on the surface of the moisture control materials, mixing the compost materials together using the fermentation promoting device after lapse of four to seven days since spraying of the excrement, and adding new moisture control materials and new excrement to existing compost materials.
Patent NZ-284706-A (NZ)
Title: Vertical staged polycondensation reactor: trays with twin loop liquid flow path
Inventor: YOUNT THOMAS LLOYD
IPC: C08F2/00
Filed: 1995-04-21
Abstract: This invention relates to a vertically disposed polymerization reactor having a series of essentially circular tray assemblies; each tray assembly having a central open vapor chimney and a single flow path composed of at least two loops wherein the liquid polymer flow is reversed by means of a substantially semi-circular turnaround wall; each tray having a liquid polymer tray inlet and a liquid polymer tray outlet for conducting a flow of the liquid polymer by means of a hydraulic gradient; each tray assembly being open at the top for escape of vapor from the liquid polymer flow to the central open vapor chimney; and each tray arranged in vertical disposition one above the other.
Patent NZ-303235-A (NZ)
Title: Arginine analogues as nitric oxide synthase inhibitors
Inventor: BROQUET COLETTE
IPC: A61P13/02
Filed: 1996-03-04
Abstract: PCT No. PCT/FR96/00337 Sec. 371 Date Sep. 10, 1997 Sec. 102(e) Date Sep. 10, 1997 PCT Filed Mar. 4, 1996 PCT Pub. No. WO96/27593 PCT Pub. Date Sep. 12, 1996A compound selected from the group consisting of a compound of the formula wherein A is selected from the group consisting of hydrogen, alkyl of 1 to 6 carbon atoms and -NO2, E is -O- or a covalent bond, n is an integer from 1 to 12, R1 and R2 are individually alkyl of 1 to 6 carbon atoms or taken together with the nitrogen to which they are attached form an optionally unsaturated 5 to 6-member ring of the formula -NX and X is selected from the group consisting of oxygen, sulfur, methylene and >N-R', R' being hydrogen or an alkyl of 1 to 6 carbon atoms, and their pharmaceutically acceptable acid addition salts useful to inhibit -NO synthase.
Patent NZ-306026-A (NZ)
Title: N-[2-hydroxy-3-sulphonyl-amino]-3-(hydrocarbylsulphonyl)hydrocarbyl-amide derivatives
Inventor: GETMAN DANIEL P
IPC: C07D263/56
Filed: 1996-03-07
Abstract: Selected sulfonylalkanoylamino hydroxyethylamine sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to such retroviral protease inhibitors and, more particularly, relates to selected novel compounds, composition and method for inhibiting retroviral proteases, such as human immunodeficiency virus (HIV) protease, prophylactically preventing retroviral infection or the spread of a retrovirus, and treatment of a retroviral infection.
Patent NZ-310644-A (NZ)
Title: Composition for sustained release of human growth hormone
Inventor: JOHNSON OLUFUNMI LILY
IPC: A61K38/27
Filed: 1996-06-03
Abstract: A composition, and methods of forming and using said composition, for the sustained release of biologically active, stabilized human growth hormone (hGH). The sustained release composition of this invention comprises a polymeric matrix of a biocompatible polymer and particles of biologically active, stabilized hGH, wherein said particles are dispersed within the biocompatible polymer. The method of the invention for producing a composition for the sustained release of biologically active hGH, includes dissolving a biocompatible polymer in a polymer solvent to form a polymer solution, dispersing particles of biologically active, metal cation-stabilized hGH in the polymer solution, and then solidifying the polymer to form a polymeric matrix containing a dispersion of said hGH particles. The method for using a composition of the invention is a method for providing a therapeutically effective blood level of biologically active, non-aggregated hGH in a subject for a sustained period. In this method, a subject is administered an effective dose of the sustained release composition of the present invention. The method of using the sustained release composition of the present invention comprises providing a therapeutically effective blood level of biologically active, non-aggregated human growth hormone in a subject for a sustained period by administering to the subject a dose of said sustained release composition.
Patent NZ-322011-A (NZ)
Title: Thermomechanically processed animal feed compositions comprising transgenic plant material
Inventor: BEUDEKER ROBERT FRANCISCUS
IPC: A23K20/189
Filed: 1996-11-06
Abstract: he present invention discloses thermomechanically processed enzyme compositions comprising transgenic plant material as active ingredient. These compositions are obtainable by subjecting raw materials containing transgenic plant material in which the polypeptide has been biosynthesized due to the expression of a transgene therein, to a thermomechanical process, such as e.g. pelleting, extrusion or expansion. The compositions of the present invention are preferably used as feed for animals or as a premix therefor.
Patent NZ-323805-A (NZ)
Title: Silane treated inorganic pigments
Inventor: WEBER LEON
IPC: C01G23/047
Filed: 1996-11-27
Abstract: The application provides a process for the production of silanized inorganic oxide pigments which comprises reacting inorganic oxide particles with organohalosilanes of the formula: RnSiX4-n preferably organochlorosilanes, to produce hydrophobic organosilane coated inorganic oxides.  It is preferred that the organohalosilane compounds be reacted with the inorganic oxide particles in an aqueous slurry and subjected to intense mixing.  The inorganic oxide pigments prepared by this processes have essentially quantitative retention of the organosilanes and contain no adsorbed aldehydes on their surface. The by-products produced in the preferred embodiments are innocuous salts, which are environmentally safe and readily disposable.
Patent NZ-329288-A (NZ)
Title: Testing animal athletic performance by measurement of three dimensional accelerations
Inventor: ROVNYI ALEXANDRE
IPC: G01P15/08
Filed: 1997-12-25
Abstract: A method of collecting and analysing acceleration information for an animal. The method utilises a microprocessor connected to an accelerometer sensor device to test the performance of a racehorse. The method comprises sensing the acceleration of an animal during a run with the accelerometer sensor device. The acceleration being sensed in at least three dimensions in the horizontal and vertical planes. Each set of acceleration values is processed to produce horizontal and vertical values.
Patent NZ-331575-A (NZ)
Title: Caffeine and N-methyl-2-[2'(alpha-methyl-p-chloro-benzhydryl-oxy)ethyl]-pyrrolidine or N-methyl-2-[2'(alpha-methyl-p-bromo-benzhydryl-oxy)ethyl]-pyrrolidine
Inventor: MITRA SEKHAR
IPC: A61K31/00
Filed: 1997-03-05
Abstract: A composition for the treatment, management or mitigation of cold, cold-like, allergy, sinus and/or flu symptoms by administering a safe and effective amount of a composition comprising caffeine and certain pyrrolidine and piperidine ether antihistaminic agents. The preferred pyrrolidine or piperidine ether antihistaminic agent is shown in the formula described. Wherein: R1 is a radical selected from H, halogen, C1-4alkyl or C1-4alkoxy; R2 is a radical selected from C1-4alkyl; m is an integer from 0-3; and n is and integer from 1-2. The composition further comprises of propionic acid derivative selected from ibuprofen, naproxen, benoxaprofen, flurbiprofen, ketoprofen, fenoprofen, miroprofen, tioxaprofen, suprofen, alminoprofen and tiaprofen.
Patent NZ-335265-A (NZ)
Title: Gas containing contrast agents that may be co-administered with vasodilator drugs to enhance differences in return signal intensity from normal and hypoperfused myocardial tissue contrast agents
Inventor: OSTENSEN JONNY
IPC: A61K49/22
Filed: 1997-10-21
Abstract: Ultrasonic visualisation of a subject, particularly of perfusion in the myocardium and other tissues, is performed using novel gas-containing contrast agent preparations which promote controllable and temporary growth of the gas phase in vivo following administration and can therefore act as deposited perfusion tracers. The preparations include a coadministerable composition comprising a diffusible component capable of inward diffusion into the dispersed gas phase to promote temporary growth thereof. In cardiac perfusion imaging the preparations may advantageously be coadministered with vasodilator drugs such as adenosine in order to enhance the differences in return signal intensity from normal and hypoperfused myocardial tissue respectively.
Patent NZ-336589-A (NZ)
Title: A process for preparing higher molecular organotin maleates which can be used for stabilising thermoplastic polymers
Inventor: CUILLERET MURIEL
IPC: C07F7/22
Filed: 1997-12-18
Abstract: A process for producing a composition containing high molecular weight organotin maleates comprises: a) reacting RA with maleic anhydride and b) then reacting the reaction mixture of part a) with either at least one dialkyltin oxide ((R1)2Sn=O) or at least one alkyltin chloride ((R1)xSnCl4-x) wherein R1 is C1-12 aliphatic hydrocarbon and n is 1 to 12. RA is: i) an alcohol ROH wherein R is a C23-50 aliphatic hydrocarbon or a mixture of saturated primary alcohol with a weight average molecular mass Mw of 340 to 718 and a polydispersity Mw/Mn of 1 or ii) an epoxyalkane CnH2nOn wherein n is 23 to 50 or a mixture of epoxyalkanes with a weight average molecular mass Mw of 338 to 716.
Patent NZ-507676-A (NZ)
Title: An improved construction of a pallet which is particularly adapted for use with forklift vehicles
Inventor: SEENEY LLOYD
IPC: B65D19/32
Filed: 2000-02-02
Abstract: A pallet formed substantially of a plastic material comprises: a substantially rectangular platform having a first surface and a second surface , a box section wall (23) formed at each of the two opposing edges of the platform to project below the second surface of the platform, the wall having longitudinal edge which is adhered to the second surface of the platform, the box section walls (23) and the platform are formed from as single sheet of the plastic material, a channel member (25) adhered to the second surface of the platform and located substantially parallel to the box section and is positioned substantially equidistantly between the two box section walls and a base member (28a,28b,28c) secured to a surface of the channel and to the box section walls to from a base which is substantially coplanar to and spaced from the second surface of the platform.
Patent NZ-510360-A (NZ)
Title: Fish gelatinous composition for use as an ingredient in tablets
Inventor: MOHR HANSEN MORTEN
IPC: A23L29/281
Filed: 1999-08-23
Abstract: A particulate composition is described comprising one or more physiologically active substances and a fish gelatinous protective colloid containing at least 50% by weight of fish gelatine, wherein the fish gelatine is at least partly composed of fish gelatine having a bloom strength of above 100, and wherein the composition is obtained by a particle forming spray congelation method or double emulsifying method.
Patent NZ-511919-A (NZ)
Title: Magnetic treatment device for fluids with inlet and outlet flows in different directions
Inventor: WHITTON VICTOR JAMES
IPC: F02M27/04
Filed: 2001-05-24
Abstract: A housing has a tubular wall 1 and two disc shaped permanent magnets 5 located at respective ends. Fluid inlet and outlet conduits 2, 3 penetrate the housing wall and are arranged so that fluid flows through these conduits in different directions.
Patent NZ-512033-A (NZ)
Title: Slide rails and shower slide rail using same.
Inventor: TURNER MARK RODNEY
IPC: A47K3/28
Filed: 2001-05-28
Abstract: A slide rail assembly comprising or including two set out members and a slide rail, each end of which is or is adapted to be received by it's set out member, said set out members locating a set distance out from a surface to which said set out members are mounted or mountable wherein at lest one (and preferably both) of said slide rail and said set out members are of a suitable stainless steel.
Patent NZ-513678-A (NZ)
Title: Integrated point-of-sale and internet system for read /writing to a data carrier
Inventor: MACSMITH DAVID
IPC: G06K17/00
Filed: 2000-02-22
Abstract: An improved system (70) for manipulating data on a plurality of data carrying devices (71) including at least one host (72) and a plurality of terminals (73). Each terminal is adapted to interact with the data carrying devices (71) and to communicate with said host (72). A first sub-set of the terminals are point of sale terminals (74) which each operate in the manner described with reference to figure 3. A second sub-set of the terminals (73) are computing means (75) capable of interfacing to the internet for communication with an internet server (77), which, in turn, is connected for communication with the host (72). This arrangement allows a user to conduct transactions with a single data carrying device (71) via either one of the POS terminals (74) or an internet server (77). The computing means (75) may be in form of a personal computer (76) having a modem (not illustrated) allowing for connection to the internet server (77). The personal computer (76) is adapted to read from, and write to, the data carrying devices (71).
Patent NZ-514309-A (NZ)
Title: Process for producing thermoplastic films by blown film extrusion and films produced thereby
Inventor: KLING SUSAN M
IPC: C08J7/046
Filed: 2000-03-07
Abstract: A process for making a thermoplastic film by the blown film extrusion process comprises extruding a molten thermoplastic polymer through a tubular die to form a tube of molten polymer, contacting the inner surface of the tube of molten polymer as it exits the die with an aqueous solution of a water-soluble polysaccharide ether, inflating the tube of molten polymer to form a blown tubular film and then collapsing the blown film to a flat web. The thermoplastic film has on its surface a coating of a water-soluble polysaccharide ether
Patent NZ-518148-A (NZ)
Title: Apparatus and methods for tendon or ligament repair
Inventor: LUBBERS LAWRENCE M
IPC: A61F2/08
Filed: 1999-10-18
Abstract: Apparatus and methods for repairing damaged tendons or ligaments. Various repair apparatus include an elongate tensile member (376) and a pair of anchor structures (390, 410) connected for movement along the tensile member (376) on either side of a repair site (370, 372), such as a tear or laceration. The anchor structures may take many forms, and may include barbed, helical, and crimp-type anchors (only helical shown). In the preferred embodiments, at least one anchor structure (390, 410) is movable along the elongate tensile member (376) to assist with adjusting a tendon segment (356) to an appropriate repair position and the anchor structure or structures (390, 410) are then lockable onto the elongate tensile member (376) to assist with affixing the tendon at the repair position. The invention further provides tendon-to-bone repair apparatus (not shown) and methods employing similar concepts. Tendon retrieval devices (not shown) of the invention include helical members (not shown) for rotating into a tendon end (not shown) and subsequently moving the tendon to an appropriate operating position.
Patent NZ-521076-A (NZ)
Title: Pharmaceutical compositions containing 3-aminoazetidine derivatives, novel derivatives and their preparation
Inventor: ACHARD DANIEL
IPC: A61P37/00
Filed: 2001-03-01
Abstract: A compound of formula (I), its preparation and pharmaceutical compositions containing as active ingredient a compound of formula (I) are disclosed, wherein: R1 represents a -NHCOR4 or -N(R5)-Y-R6 radical; Y is SO2; R4 represents an -alk-SO2R11, -alk-SO2-CH=CH-R11, Het substituted by -SO2R11 or phenyl substituted by -SO2-R11 or -alk-SO2-R11 radical; R5 represents a hydrogen atom or an alkyl radical; R6 represents a phenylalkyl radical, Het or Ar; wherein alk, Ar and R11 are as defined in the specification.
Patent NZ-521470-A (NZ)
Title: Use of aloe vera and trigylcerides as intradermal-penetration agents for topical local anesthetic administration
Inventor: FISCHER WILFRIED
IPC: A61K47/44
Filed: 2001-03-06
Abstract: A patch comprising a backing and a pressure sensitive acrylic adhesive, which adhesive comprises a therapeutically effective amount of a local anesthetic preferably lidocaine or a pharmaceutically acceptable salt thereof and a penetration enhancing amount of a triglyceride preferably soybean oil is disclosed. The adhesive may further contain an aloe composition preferably aloe-vera gel.
Patent NZ-523532-A (NZ)
Title: Method for conducting royalty transactions
Inventor: EASON STUART
IPC: G06Q10/08
Filed: 2003-01-08
Abstract: A method of managing transactions conducted between a royalty owner of one or more varieties of royalty products and one or more vendors of the products wherein each product sold includes a label, which is distinct for each variety of product, includes: a system administrator provides and maintains an administration computer hosting an administration database, the royalty owner being linkable to the administration computer via a computer network; royalty value data corresponding to a royalty value for each distinctive label is entered into the administration database; quantity supplied data corresponding to the quantity of each distinctive label supplied to each vendor is entered into the administration database; royalty charged data corresponding to the royalty value data multiplied by the quantity supplied data is calculated by the administration computer and retained by the administration database; royalty collected data corresponding to the royalties collected from the vendor is entered into the administration database; wherein the owner controls the supply of labels to each vendor based on the data on the administration database.
Patent NZ-524805-A (NZ)
Title: Adenoviral vectors with a tropsim for skeletal muscle cells or myoblasts
Inventor: HAVENGA MENZO JANS EMCO
IPC: C07K14/075
Filed: 2001-09-25
Abstract: A recombinant adenovirus having a tropism for skeletal muscle cells and/or myoblasts cells is used as a vehicle for delivering a nucleic acid of interest to a skeletal muscle cell and/or myoblast cell in vitro wherein the recombinant adenovirus comprises at least a tropism determining part of an adenoviral fiber protein having a tropism for skeletal muscle cells and/or myoblast cells and wherein the tropism determining part of the fiber protein is a fiber protein of an adenovirus of serotype 11, 16, 35, 38, 40-S 40-L or 51. The recombinant adenovirus can also be used in the manufacture of a medicament for the treatment of a disease which affects skeletal muscle cells and/or myoblasts such as Duchenne muscular dystrophin, a glycogen storage disorder or a cardiovascular disease. Also described is an in vitro skeletal muscle cell and/or myoblast comprising a nucleic of interest delivered to the cell by the adenovirus and a pharmaceutical composition comprising the cell.
Patent NZ-528466-A (NZ)
Title: Antimicrobial compositions
Inventor: OHNISHI TOSHIMASA
IPC: A01N43/64
Filed: 2002-03-04
Abstract: An antimicrobial composition comprising 3- benzo[b]thiene-2-yl-5,6-dihydro-1,4,2-oxathiazine-4-oxide and one or more of the following compounds (a) 1-[[(3-iodo- 2-propynyl)oxy]methoxy]-4-methoxy benzene, (b) 1-chloro-4- [[(3-iodo-2-propynyl)oxy]methoxy] benzene, (c) zinc 2- pyridine thiol-1-oxide, (d) copper 2-pyridine thiol-1- oxide, (e) 2-pyridine thiol-1-oxide sodium salt, (f) 2,2- dithio-bis(pyridine-1-oxide), (g) 2-methylthio-4-t-butyl amino-6-cyclopropyl amino-s-triazine, (k) (2,4,5,6- tetrachloro-1,3-benzenedicarbonitrile, (l) 1,1-dichloro-N- [(dimethylamino)sulfonyl]-1-fluoro-N--phenyl methanesulfenamide, or (m) 1,1-dichloro-N- [(dimethylamino)sulfonyl]-1-fluoro-N-(4-methylphenyl)- methanesulfenamide; in synergistically effective amounts.
Patent NZ-528732-A (NZ)
Title: Plant container liners
Inventor: KEE PETER BRADLEY
IPC: A01G9/02
Filed: 2003-10-08
Abstract: A method of forming a liner for a plant container or a blank therefor, the method including: (a) forming a first layer (64) of compressed sphagnum moss which is dry or at least partially dried such that it is reconstitutable; and (b) incorporating a layer (62) of water-resistant material into the liner or blank. (62) Divided out of 526234